07:00 , Sep 5, 2016 |  BC Week In Review  |  Company News

DS Biopharma deal

DS Biopharma spun out Afimmune, which will focus on fibrotic and pulmonary diseases. The newco will develop DS Biopharma’s DS102 and other undisclosed preclinical compounds. DS102, a bioactive lipid produced by the non-enzymatic oxidation of...